Navigation Links
Pets Best Insurance Announces Stem Cell Therapy and Regenerative Veterinary Medicine by Vet-Stem, Inc. Covered by Their Pet Health Insurance
Date:9/24/2013

Poway, California (PRWEB) September 24, 2013

Vet-Stem, Inc., the world's leading Regenerative Veterinary Medicine company, is pleased to announce that Pets Best Insurance plans provide coverage for Regenerative Stem Cell Therapy. Pets Best Insurance knows that with pets come vet bills, especially when a pet is suffering from the pain of injury or arthritis. Pets Best Insurance wants the best for pets and their owners and Vet-Stem offers the best in regenerative medicine for them. Pet’s suffering from pain of osteoarthritis, joint issues, and injuries of the muscle, tendon and ligament can now be given stem cell therapy.

Vet-Stem first offered stem cell therapy for dogs and cats in 2007. One of the success stories and stem cell advocates is part of the Pet’s Best Insurance family, Jetta, owned by Greg McDonald, CEO of Pets Best Insurance.

Jack L. Stephens, DVM and President/Founder of Pets Best Insurance talks about Greg’s experience: "Our CEO had a wonderful experience utilizing Vet-Stem therapy in his twelve year old lab. He loved throwing, and she loved chasing, a ball every evening. But as she aged, she just could not do it due to severe arthritis. Surgery was not a viable alternative and he asked me about stem cell therapy. I told him we had seen claims with the treatment and it was covered with our insurance. He had it done, her condition very much improved and she was able to chase the ball again. Pets Best Insurance provides full coverage for Vet-Stem Regenerative Cell Therapy, in fact we were early adopters of providing coverage and paying for the therapy. Any procedure performed by practicing veterinarians that helps pets, we are in favor of.”

"We are proud that so many dog owners and veterinarians have placed their trust in Vet-Stem Cell therapy. We feel a great sense of accomplishment knowing that there are thousands of dogs and dog owners who have experienced the benefit of stem cell technology. This practical and beneficial application of technology puts stem cell therapy into the present day instead of a future theoretical concept. The fact that Pets Best provides coverage for our therapy is an added plus and makes this a viable treatment option for many more pet owners," said Robert Harman, DVM, MPVM, Founder and CEO of Vet-Stem.

For more information about Pets Best Insurance visit http://www.petsbest.com

About Vet-Stem, Inc.
Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.’s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure. For more on Vet-Stem, Inc. and Veterinary Regenerative Medicine visit http://www.vet-stem.com or call 858-748-2004.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11151135.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. CSL Behring Awards LEAD Grant to Patient Organizations to Educate Constituents on State Insurance Exchanges
2. Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager
3. WestPark Capitals Michael Wechsler Comments on the Life Insurance Market
4. Medical Concierge Travel International launches in Tandem with Leading Medical Cost Containment Company, EME International aimed at Self-Funded and Insurance Companies
5. Medtech College Recognizes Medical Billers & Coders For "Cracking The Code" Of Insurance, Patient And Physician Billing
6. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
7. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
8. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
9. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
10. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
11. WuXi PharmaTech Announces Third-Quarter 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):